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Objectives: To observe the prevalence of methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant S. aureus (VRSA), and Panton-Valentine leukocidin (PVL)-positive S. aureus, this
study was carried out in a tertiary care hospital in Dhaka, Bangladesh.
Materials and methods: S. aureus strains were recovered from 200 postoperative wound swab samples
from patients hospitalized in Dhaka Medical College Hospital between July 2011 and June 2012. Meth-
icillin resistance was determined by the oxacillin and cefoxitin disc diffusion method, the minimum
inhibitory concentration (MIC) of oxacillin, and mecA gene detection. VRSA resistance was determined by
the disc diffusion method, the MIC of vancomycin, and screening for the vanA and vanB genes. The PVL
gene was also detected in MRSA strains.
Results: Fifteen of the 44 isolated strains of S. aureus were MRSA (2 of them were VRSA) and 29 were
methicillin-sensitive S. aureus. All MRSA isolates were highly resistant to oxacillin (MIC  256 mg/mL).
When compared with polymerase chain reaction (PCR), the sensitivity and speciﬁcity of the oxacillin disc
diffusion method were 93.33% and 100% respectively; for the cefoxitin disc diffusion method and MIC of
oxacillin both the sensitivity and speciﬁcity were 100%. Four (26.67%) MRSA isolates were positive for
PVL genes which were also mecA positive. The MRSA strains were highly resistant to ciproﬂoxacin
(93.33%), ceftriaxone (86.63%), azithromycin (73.33%), gentamycin (73.33%), and amoxiclav (66.67%). All
(100%) MRSA strains were sensitive to linezolid and 86.67% were sensitive to vancomycin. The VRSA
strains had an MIC 256 mg/mL for vancomycin and were positive for the vanB gene but negative for the
vanA gene.
Conclusion: The results of this study provide insight into the high proportion of MRSA and presence of
VRSA in Bangladesh.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Infections caused by Staphylococcus aureus, especially
methicillin-resistant S. aureus (MRSA), are emerging as a major
public health problem in hospital and community settings, causingogy, Dhaka Medical College,
229, Bangladesh. Tel.: þ880 1
Islam).
elief Tzu Chi Foundation. Publishea wide range of diseases. The emergence and spread of both health
care and community-associated MRSA has made infection control
intervention and treatment challenging [1].
MRSA has evolved after acquiring themecA gene that encodes the
penicillin-binding protein 2a which confers resistance to methicillin
and other b-lactam antibiotics [2]. The mecA is a highly conserved
gene found only in methicillin-resistant strains with no allelic
equivalent inmethicillin-susceptible Staphylococci, making it a useful
marker for b-lactam resistance [3]. Detection of themecA gene is the
gold standard for identifyingMRSA [4] but this test is not available in
many clinical laboratories in developing countries and is relatively
expensive. Different methods have been developed for the detectiond by Elsevier Taiwan LLC. All rights reserved.
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oxacillin screening agarmethod, anddisc diffusion testing. Themajor
problem in routine screening is thatMRSA strains are heterogeneous
in the expression of resistance to b-lactam agents [5].
S. aureus produces numerous virulence factors, including
Panton-Valentine Leukocidin (PVL), which is a pore forming cyto-
toxin more often identiﬁed in community-associated MRSA strains
than hospital-associated strains [6]. PVL-positive Staphylococcal
infection typically presents as a life-threatening infection of the
skin and soft tissues, bone, or joints, although it can also lead to
necrotizing pneumonia, a severe and often fatal condition involving
primarily young, healthy patients [3,6].
In 1996, VISA (vancomycin-intermediate S. aureus) was ﬁrst
reported in Japan [7], and then in 2002 vancomycin-resistant
S. aureus (VRSA) was ﬁrst reported in the USA [8]. Subsequent
isolation of VRSA from different countries has conﬁrmed that the
emergence of these strains is a global issue [9e12].
The aim of this study was to determine the prevalence of MRSA
and VRSA in postoperative wound swabs using antimicrobial sus-
ceptibility proﬁles and to detect the PVL andmecA genes inMRSA as
well as the vanA and vanB genes in VRSA.
2. Materials and methods
2.1. Samples
Twohundred swab sampleswere collected from infectedwounds
from postoperative patients admitted to Dhaka Medical College
Hospital (DMCH) in Bangladesh over a 12-month period from July
2011 to June 2012. The age and sex of patients were recorded.
2.2. Inclusion criteria
Wound swabs collected from patients admitted to DMCH irre-
spective of age, sex, and antibiotic intake. Urine samples received in
the Department of Microbiology of DMCH for culture and sensi-
tivity irrespective of age, sex, and history of antibiotic intake were
also included.
2.3. Ethical issues
Informed written consents were taken from each patient prior
to collecting samples. Approval was obtained from the Research
Review Committee and Ethical Review Committee of Dhaka Med-
ical College according to the Declaration of Helsinki and national
and institutional standards.
2.4. Isolation of S. aureus
S. aureus was identiﬁed by observing opaque colonies on blood
agar media, Gram's staining, positive catalase and coagulase tests,
and mannitol fermentation on mannitol salt agar [13].
2.5. Antimicrobial susceptibility testing
Standard disc diffusion techniques as recommended by the
Clinical Laboratory Standards Institute (CLSI) were performed for
susceptibility testing of oxacillin, cefoxitin, gentamycin, cotrimox-
azole, ciproﬂoxacin, ceftriaxone, amoxiclav, vancomycin, and line-
zolid (oxoid, UK) for all S. aureus. [14].
2.6. Detection of MRSA and VRSA by the disc diffusion technique
Screening for methicillin-resistance was determined using the
Kirby-Bauer disc diffusion method with 1 mg oxacillin and 30 mgcefoxitin discs. VRSA was detected by a 30 mg vancomycin disc.
Three to ﬁve were emulsiﬁed into 3 mL of sterile normal saline. The
turbidity of the suspension was compared with the 0.5 McFarland
turbidity standard and the suspension was incubated on Muel-
lereHinton agar plates at 37C for 24 hours. An inhibition zone
diameter of  10 mm around the oxacillin disc was considered
resistance; 11e12 mm indicated intermediate, and  13 mm was
considered sensitive. For the cefoxitin disc, an inhibition zone
diameter of  21 mmwas considered resistance and  22 mmwas
considered sensitive [14].
2.7. Detection of MRSA by the MIC of oxacillin and VRSA by MIC of
vancomycin
The MIC of oxacillin by the agar dilution method was deter-
mined according to CLSI guidelines. An MIC of oxacillin  4 mg/mL
was considered MRSA and  2 mg/mL was considered methicillin-
sensitive S. aureus (MSSA) [14]. For preparation of the oxacillin
stock solution, a 500-mg base of oxacillin was added to 50 mL
distilled water to a concentration of 10 mg/mL. For each plate,
50 mL MuellereHinton medium was prepared and impregnated
with 10 mL, 20 mL, 40 mL, 80 mL, 160 mL, 320 mL, 640 mL, or 1280 mL of
the oxacillin stock solution to achieve concentrations of 2 mg/mL,
4 mg/mL, 8 mg/mL, 16 mg/mL, 32 mg/mL, 64 mg/mL, 128 mg/mL, or
256 mg/mL per plate, respectively.
For detection of VRSA, an MIC of vancomycin  16 mg/mL was
considered resistant,  2 mg/mL was sensitive, and 4e8 mg/mL was
VISA [14]. A vial of a 500 mg base of commercially available van-
comycin injection was added to 50 mL distilled water to a con-
centration of 10 mg/mL. For each plate, 50 mL sterile
MuellereHinton agar was prepared and impregnated with 10 mL,
20 mL, 40 mL, 80 mL, 160 mL, 320 mL, 640 mL, or 1280 mL of vancomycin
stock solution to achieve a concentration of 2 mg/mL, 4 mg/mL, 8 mg/
mL, 16 mg/mL, 32 mg/mL, 64 mg/mL, 128 mg/mL, or 256 mg/mL per
plate, respectively.
2.8. DNA extraction
DNA was extracted using the boiling method. Bacterial colonies
were suspended in 300 mL of distilled water and boiled for 10 mi-
nutes in a heat block, then placed on ice for 5 minutes. After
centrifugation at 13,000  g at 4C for 5 minutes, the supernatant
was placed in a microtube and kept at 4C until used as a DNA
template [15].
2.9. Ampliﬁcation of mecA and PVL genes
ThemecA genewas ampliﬁed as described previously [16], using
primers mecA-F: 50-AAAATCGATGGTAAAGGTTGGC-30 and mecA-R:
50-AGTTCTGCAGTACCGGATTTTGC-30. The DNA of the S. aureus ATCC
43300 and ATCC 25923 strains was used as positive and negative
controls, respectively, for this polymerase chain reaction (PCR)
assay of mecA. The PCR assay was performed in a total volume of
25 mL containing 10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2,
0.25 mM each deoxynucleotide triphosphate (dATP, dCTP, dGTP,
and dTTP), and 1 U of Taq DNA polymerase (Promega Corporation,
USA). DNA ampliﬁcation was carried out using the following ther-
mal cycling proﬁle: initial denaturation at 95C for 10 minutes, 35
cycles of ampliﬁcation (denaturation at 95C for 45 seconds,
annealing at 55C for 45 seconds, and extension at 72C for 1
minute), and a ﬁnal extension at 72C for 10 minutes in a thermal
cycler (Mastercycler gradient, Eppendorf AG, Germany). PCR
products were analyzed on 1.5% agarose gel with 0.53 Tris-borate-
EDTA buffer. A 100-bp DNA ladder (Promega Corporation) was used
Figure 1. Ampliﬁed DNA of the mecA gene in Staphylococcus aureus. Negative control
S. aureus ATCC 25923 (Lane 1) and positive control ATCC 43300 (Lane 2). Ampliﬁed
DNA of 533 bp for the mecA gene (Lanes 3, 5, and 6). Hundred base pair DNA ladder
(Lane 4).
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ethidium bromide and visualized under UV light [16].
The PVL gene was ampliﬁed as described previously [6,15].
Primers lukSF- forward (50- ATCATTAGGTAAAATGTCTGGA-
CATGATCCA-30) and lukSF- reverse (50- GCATCAASTGTATTGGA-
TAGCAAAAGC-30) directed against the PVL S and F precursor genes
(lukS/F-PV) were used. DNA ampliﬁcationwas carried out using the
following thermal cycling proﬁle: initial denaturation at 95C for 10
minutes, 33 cycles of ampliﬁcation (denaturation at 95C for 30
seconds, annealing at 55C for 45 seconds, and extension at 72C
for 1 minute), and a ﬁnal extension at 72C for 10 minutes in a
thermal cycler (Mastercycler gradient, Eppendorf AG). The PCR
products were analyzed on 1.5% agarose gel with 0.53 Tris-borate-
EDTA buffer. A 100-bp DNA ladder (Promega Corporation) was used
as the molecular size marker. The gels were stained with 1%
ethidium bromide and visualized under UV light [15]. The DNA of
the S. aureus ATCC 25923 strainwas used as the negative control for
the PVL gene assay.Figure 2. Ampliﬁed DNA of the PVL gene in Staphylococcus aureus. Ampliﬁed DNA of
433 bp for the PVL gene (Lanes 1, 2, 4, and 5). Hundred base pair DNA ladder (Lane 3).
PVL¼ Panton-Valentine leukocidin.2.10. Ampliﬁcation of the vanA and vanB genes
The VRSA isolates were ampliﬁed using the primers for vanA
(vanA F 50-ATGAATAGAATAAAAGTTGCAATA-30 and R 50-
CCCCTTTAACGCTAATACGATCAA-30) and vanB (vanB F 50- GTGA-
CAAACCGGAGGCGAGGA-30 and R 50- CCGCCATCCTCCTGCAAAAAA-
30) [11,17]. The PCR assay was performed in a total volume of 25 mL
containing 10mM Tris-HCl, 50mM KCl, 1.5mMMgCl2, 0.25mM each
of deoxynucleotide triphosphate (dATP, dCTP, dGTP, and dTTP), and
1 U of Taq DNA polymerase (Promega Corporation). DNA ampliﬁ-
cation was carried out using the following thermal cycling proﬁle:
initial denaturation at 95C for 10 minutes, 33 cycles of ampliﬁca-
tion (denaturation at 95C for 45 seconds, annealing at 54C for 45
seconds, and extension at 72C for 1 minute), and a ﬁnal extension
at 72C for 10 minutes in a thermal cycler (Mastercycler gradient,
Eppendorf AG). The PCR products were analyzed on 1.5% agarose
gel with 0.53 Tris-borate-EDTA buffer. A 100-bp DNA ladder
(Promega Corporation) was used as the molecular size marker. The
gels were stained with 1% ethidium bromide and visualized under
UV light [11].Figure 3. Ampliﬁed DNA of the vanB gene in Staphylococcus aureus. Ampliﬁed DNA of
433 bp for the vanB gene (Lanes 1 and 3). Hundred base pair DNA ladder (Lane 2).3. Results
Fifteen of the 44 isolated strains of S. aureus (34.09%)wereMRSA
as identiﬁed by the cefoxitin disc diffusion method and the MIC of
oxacillin, and all of them were mecA positive on PCR. Fourteen
(31.82%) strains were resistant to methicillin based on the oxacillin
disc diffusion method. Four (26.67%) of the 15mecA positive strains
were also positive for the PVL gene. MRSA colonizationwas highest
in patients aged between 40 years and 55 years with male and
female distributions of 73.33% and 26.67%, respectively.
Representative PCR ampliﬁed mecA, PVL, and vanB genes are
shown in Figs. 1e3, respectively. The sensitivity, speciﬁcity, positive
predictive value, and negative predictive value of the three
phenotypic methods in comparisonwith the molecular method are
shown in Table 1. The cefoxitin disc diffusion method was superior
to the oxacillin disc diffusion method for detection of MRSA and
was comparable to the MIC of oxacillin.
All the isolates were susceptible to linezolid. MRSA strains
showed higher resistance than the other strains to all antimicro-
bials except for vancomycin (Table 2). All (100%) of the PVL positive
strains were sensitive to amoxiclav, vancomycin, and linezolid,
three (75%) were sensitive to azithromycin, two (50%) were resis-
tant to ceftriaxone and gentamycin, and three (75%) were resistant
to ciproﬂoxacin.
Table 1
Sensitivity, speciﬁcity, PPV, and NPV of disc diffusion methods and MIC compared
with mecA gene for detection of MRSA.
Methods No. of
MRSA
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
Oxacillin disc
diffusion
14 93.33 100 100 96.67
Cefoxitin disc
diffusion
15 100 100 100 100
MIC of oxacillin 15 100 100 100 100
MIC ¼ minimum inhibitory concentrations; MRSA ¼ methicillin-resistant Staphy-
lococcus aureus; NPV ¼ negative predictive value; PPV ¼ positive predictive value.
Table 2
Antimicrobial susceptibility pattern of Staphylococcus aureus and MRSA strains.
Antibiotics
Staphylococcus aureus (n ¼ 44) MRSA (n ¼ 15)
Resistant Sensitive Sensitive Resistant
Ceftriaxone 15 (34.10) 29 (65.90) 2 (13.33) 13 (86.67)
Ciproﬂoxacin 25 (56.82) 19 (43.18) 1 (6.67) 14 (93.33)
Azithromycin 18 (40.91) 26 (49.09) 4 (26.67) 11 (73.33)
Amoxiclav 13 (29.55) 31 (70.45) 5 (33.33) 10 (66.67)
Gentamycin 14 (31.82) 30 (68.18) 4 (26.67) 11 (73.33)
Oxacillin 14 (31.82) 30 (68.18) 1 (6.67) 14 (93.33)
Cefoxitin 15 (34.10) 29 (65.90) 0 (0.00) 15 (100.00)
Vancomycin 2 (4.55) 42 (95.45) 13 (86.67) 2 (13.33)
Linezolid 0 (0.00) 44 (100.00) 15 (100.00) 0 (0.00)
Data are presented as n (%).
MRSA ¼ methicillin-resistant Staphylococcus aureus.
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256 mg/mL and the other was 256 mg/mL. Both were positive for the
vanB gene and neither was positive for the vanA gene. Both VRSA
strains were sensitive to linezolid, one was sensitive to gentamycin
and the other was sensitive to azithromycin (Table 3). No VISA was
observed.
4. Discussion
Infections caused by drug resistant S. aureus are increasing
worldwide due to the emergence of MRSA and VRSA. The prompt
and accurate detection of MRSA and VRSA isolates could be useful
for determining the appropriate treatment strategy and subsequent
effective management and control of corresponding infections.
We found that the prevalence of MRSA was 34.09%, which cor-
relates with previous reports from other regions of Bangladesh,
Pakistan, and India [18e21]. However, some studies have reported
much higher rates of 64e88% [17,22]. The exact cause of the rela-
tively low prevalence of MRSA in the present study in comparison
to other countries is not known but it is possible that the prevalence
of MRSA is still low in Bangladesh. Moreover, the samples in the
present studywere taken frompostoperative patients with infected
wounds. The prevalence could have been higher if the samples had
been taken from patients in the burn unit or casualty ward. TheTable 3
Antimicrobial resistance pattern of VRSA strains.
Patient MIC of VA
(mg/mL)
Antimicrobials
CIP CRO AZM CN AMC OX FOX VA LZD
1 >256 R R R S R R R R S
2 256 R R S R R R R R S
AMC ¼ amoxiclav; AZM ¼ azithromycin; CIP ¼ ciproﬂoxacin; CN ¼ gentamycin;
CRO ¼ ceftriaxone; FOX ¼ cefoxitin; LZD ¼ linezolid; MIC ¼ minimum inhibitory
concentration; OX ¼ oxacillin; VA ¼ vancomycin.prevalence of MRSA varies signiﬁcantly in different regions, which
suggests a need for periodic evaluation of MRSA [23]. The
increasing prevalence of MRSA is a threat to management of cases
all over the world, including Bangladesh.
As described in other studies [24,25], our MRSA isolates were
resistant to most commonly used antibiotics. All MRSA isolates
were sensitive to linezolid and 86.67% were sensitive to vancomy-
cin, similar to other studies. This suggests that these drugs could be
suitable treatment options [19,20,26]. As these drugs are expensive
and sometimes not available in the local pharmaceutical market,
treatment options in Bangladesh are limited for infections caused
by MRSA.
In this study, MRSA strains had an MIC of oxacillin  256 mg/mL.
Some authors from Iran reported that most MRSA strains are highly
resistant to oxacillin (MIC  256 mg/mL), similar to our study [17].
The higher MIC of oxacillin in the present study might be due to the
fact that common antibiotics are sold over the counter in
Bangladesh and anybody can buy them without a doctor's advice.
This might cause development of resistance to antibiotics.
Some authors from Bangladesh reported a PVL positive S. aureus
rate of 15.25%, but no PVL was detected in MRSA strains [27].
However, in this study, the PVL gene was detected in four (26.67%)
of the MRSA isolates which were hospital acquired MRSA. In the
present study, however, MSSA strainswere not screened for the PVL
gene. Therefore, a surveillance mechanism should be set up to
detect PVL genes in both MRSA and MSSA in Bangladesh. Usually
PVL positive strains are found in community acquiredMRSA but the
PVL gene is not restricted to community acquired strains [28]. Some
authors from India reported that 68e85% of MRSA strains were
positive for the PVL gene, which is much higher than in the present
study [21,29]. The higher percentages in those studies might be due
to misuse of antibiotics causing selective pressure for development
of resistant strains along with the PVL virulence factor in those
countries. The presence of PVL is associated with increased viru-
lence of certain strains of S. aureus and is the cause of necrotic le-
sions involving the skin and mucosa which are very difﬁcult to
manage, such as necrotic hemorrhagic pneumonia. Therefore, early
detection of the PVL gene in S. aureusmay be important to manage
cases and to assess the outcome after treatment.
In the present study, both the sensitivity and speciﬁcity of the
cefoxitin disc diffusion method and the MIC of oxacillin were 100%
when compared with PCR and these results are similar to those in
other studies [30e32]. The sensitivity and speciﬁcity of the oxacillin
disc diffusion method were 93.33% and 100% respectively in the
present study, which correlates with another study [33]. We
showed the cefoxitin disc diffusion method correlated better with
the presence of the mecA gene. Cefoxitin is a potent inducer of the
mecA regulatory system and is being widely used as a marker for
mecA gene-mediated methicillin resistance [4]. Some reports
showed almost no discrepancy between cefoxitin susceptibility
testing and PCR results for themecA gene [23,34]. The oxacillin disc
diffusion method is used to identify MRSA in most laboratories in
Bangladesh. However, false negative as well as false positive results
may be obtained using this method. This problem can be overcome
by using cefoxitin discs instead of oxacillin discs to detect MRSA.
VRSA had not been detected previously in Bangladesh but the
present study showed its emergence, which is a problem in treat-
ment. Both VRSA isolates in the present study were resistant to
several antimicrobials, but not linezolid, which is in accordance
with other reports [10]. In the present study, one VRSA strain had
anMIC of vancomycin of 256 mg/mL and the other was> 256 mg/mL,
whereas VRSA isolated in other countries hadMICs 32e1024 mg/mL
[9e11,35]. In the present study, however, VRSA strains were not
tested for MICs > 256 mg/mL. Most VRSA isolated worldwide carries
the vanA gene. However, in our study, neither strainwas positive for
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Some authors from India, Cairo, and Iran have reported vanB gene-
positive VRSA [12,36,37]. The prevalence of the vanA gene among
VRSA isolates has been reported in some studies worldwide. The
reason behind the absence of vanA gene in the present study might
be differences in the geographical distribution of van genes in
VRSA. The low number of isolated VRSA strains might also be the
reason. In the present study, no VISA was identiﬁed.
5. Conclusion
Multidrug-resistant S. aureus, including MRSA, is increasing at
DMCH in Bangladesh. Some of the MRSA are PVL positive. To the
best of our knowledge, this is the ﬁrst report of VRSA identiﬁed by
phenotype, the MIC of vancomycin, and vanB gene detection in
Bangladesh. A decreased sensitivity of MRSA and VRSA to
commonly used antibiotics has been observed. This study suggests
that efﬁcient control protocols should be adopted in hospitals to
prevent the transfer of these strains between patients. Moreover,
the rational use of effective antibiotics and prevention of their sale
over-the-counter should also be considered.
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